Clinical Trial Diversity: We Must ‘Turn This Moment Into A Movement’
Executive Summary
Pfizer and Genentech execs describe steps they’ve taken to increase diversity in clinical trials from moving trial sites into new neighborhoods to modifying protocols and holding others accountable for diversity.